EPIGENE: genome-wide transcription unit annotation using a multivariate probabilistic model of histone modifications

• Published in: Epigenetics & chromatin 2020-04, Vol.13 (1), p.20-20, Article 20
• Main Authors: Sahu, Anshupa, Li, Na, Dunkel, Ilona, Chung, Ho-Ryun
• Format: Article
• Language: English
• Subjects: Analysis; Annotations; Cell lines; Cells (Biology); Chromatin; Chromatin Immunoprecipitation Sequencing - methods; DNA-directed RNA polymerase; Epigenetic inheritance; Epigenetics; Epigenomics - methods; Gene expression; Genes; Genetic aspects; Genomes; Genomics; Hep G2 Cells; Hidden Markov model; Histone Code; Histone modifications; Humans; Identification; K562 Cells; Markov Chains; Markov processes; Messenger RNA; Methodology; MicroRNA; MicroRNAs; miRNA; Molecular Sequence Annotation - methods; Phosphorylation; RNA polymerase; Segmentation; Software; Transcript identification; Transcription; Transcription (Genetics); Transcription Initiation Site; Transcriptome
• ISSN: 1756-8935; 1756-8935
• DOI: 10.1186/s13072-020-00341-z

Understanding the transcriptome is critical for explaining the functional as well as regulatory roles of genomic regions. Current methods for the identification of transcription units (TUs) use RNA-seq that, however, require large quantities of mRNA rendering the identification of inherently unstable TUs, e.g. miRNA precursors, difficult. This problem can be alleviated by chromatin-based approaches due to a correlation between histone modifications and transcription. Here, we introduce EPIGENE, a novel chromatin segmentation method for the identification of active TUs using transcription-associated histone modifications. Unlike the existing chromatin segmentation approaches, EPIGENE uses a constrained, semi-supervised multivariate hidden Markov model (HMM) that models the observed combination of histone modifications using a product of independent Bernoulli random variables, to identify active TUs. Our results show that EPIGENE can identify genome-wide TUs in an unbiased manner. EPIGENE-predicted TUs show an enrichment of RNA Polymerase II at the transcription start site and in gene body indicating that they are indeed transcribed. Comprehensive validation using existing annotations revealed that 93% of EPIGENE TUs can be explained by existing gene annotations and 5% of EPIGENE TUs in HepG2 can be explained by microRNA annotations. EPIGENE outperformed the existing RNA-seq-based approaches in TU prediction precision across human cell lines. Finally, we identified 232 novel TUs in K562 and 43 novel cell-specific TUs all of which were supported by RNA Polymerase II ChIP-seq and Nascent RNA-seq data. We demonstrate the applicability of EPIGENE to identify genome-wide active TUs and to provide valuable information about unannotated TUs. EPIGENE is an open-source method and is freely available at: https://github.com/imbbLab/EPIGENE.